4//SEC Filing
Koppikar Utpal 4
Accession 0001140361-22-019988
CIK 0001604464other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:16 PM ET
Size
6.3 KB
Accession
0001140361-22-019988
Insider Transaction Report
Form 4
Koppikar Utpal
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-05-17$5.32/sh−4,616$24,539→ 208,558 total - Sale
Common Stock
2022-05-17$5.32/sh−966$5,136→ 207,592 total
Footnotes (2)
- [F1]Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 17, 2022 and May 18, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001742696
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:16 PM ET
- Size
- 6.3 KB